Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy
STAFFORD, Texas, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq:…
Vireo Growth Inc. to Acquire Additional Outstanding Senior Secured Convertible Notes of Schwazze
December 19, 2025 18:10 ET | Source: Vireo Growth Inc. MINNEAPOLIS, Dec.…
Sequana Medical Announces Granting of Key Additional U.S. Patent for DSR
Ghent, Belgium, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Builds upon existing granted…
BREAKWATER ENERGY HOLDINGS S. R.L. ANNOUNCES PRICING OF AN ADDITIONAL $75 MILLION OF ITS 9% SENIOR SECURED NOTES DUE 2030
LUXEMBOURG, Dec. 16, 2025 /PRNewswire/ -- Breakwater Energy Holdings S.à r.l. (the…
India Deep Tech Alliance Announces Second Wave of Members, Additional 7,500 Crore ($850+ Million USD) Capital Commitments
Alliance expands roster of deep tech venture investors committed to making long‑term,…
ROCK & ROLL HALL OF FAME ANNOUNCES ADDITIONAL PRESENTERS AND PERFORMERS FOR 2025 INDUCTION CEREMONY
More Stars Join the Celebration of Music's Highest Honor, Streaming Live on…
Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025
October 25, 2025 11:01 ET | Source: Cullinan Therapeutics, Inc. CLN-978 led…
EquiLend’s 1Source Goes Live With BNY and National Bank of Canada. Additional Counterparties to Follow
A major step toward unified trade reconciliation across securities finance NEW YORK,…
Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares for Gross Proceeds of $345 Million
SAN FRANCISCO and BOSTON, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics,…
Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation
Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment…
